1848P Safety and efficacy of immune checkpoint inhibitors in patients with cancer and hepatitis B: Multicentre experience.
Saved in:
| Title: | 1848P Safety and efficacy of immune checkpoint inhibitors in patients with cancer and hepatitis B: Multicentre experience. |
|---|---|
| Authors: | Bas, O.1 (AUTHOR), Sert, L.2 (AUTHOR), Balcik, O.Y.3 (AUTHOR), Tokatli, M.4 (AUTHOR), Boyraz, N.E.4 (AUTHOR), Kavgaci, G.5 (AUTHOR), Sahin, T.K.6 (AUTHOR), Guven, D.C.7 (AUTHOR), Arik, Z.8 (AUTHOR), Isikdogan, A.2 (AUTHOR), Erman, M.9 (AUTHOR) |
| Source: | Annals of Oncology. 2024 Supplement 2, Vol. 35, pS1090-S1090. 1p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 179693285 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: 1848P Safety and efficacy of immune checkpoint inhibitors in patients with cancer and hepatitis B: Multicentre experience. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Bas%2C+O%2E%22">Bas, O.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sert%2C+L%2E%22">Sert, L.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Balcik%2C+O%2EY%2E%22">Balcik, O.Y.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tokatli%2C+M%2E%22">Tokatli, M.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Boyraz%2C+N%2EE%2E%22">Boyraz, N.E.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kavgaci%2C+G%2E%22">Kavgaci, G.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sahin%2C+T%2EK%2E%22">Sahin, T.K.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Guven%2C+D%2EC%2E%22">Guven, D.C.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Arik%2C+Z%2E%22">Arik, Z.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Isikdogan%2C+A%2E%22">Isikdogan, A.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Erman%2C+M%2E%22">Erman, M.</searchLink><relatesTo>9</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2024 Supplement 2, Vol. 35, pS1090-S1090. 1p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=179693285 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.annonc.2024.08.1943 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 1 StartPage: S1090 Titles: – TitleFull: 1848P Safety and efficacy of immune checkpoint inhibitors in patients with cancer and hepatitis B: Multicentre experience. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Bas, O. – PersonEntity: Name: NameFull: Sert, L. – PersonEntity: Name: NameFull: Balcik, O.Y. – PersonEntity: Name: NameFull: Tokatli, M. – PersonEntity: Name: NameFull: Boyraz, N.E. – PersonEntity: Name: NameFull: Kavgaci, G. – PersonEntity: Name: NameFull: Sahin, T.K. – PersonEntity: Name: NameFull: Guven, D.C. – PersonEntity: Name: NameFull: Arik, Z. – PersonEntity: Name: NameFull: Isikdogan, A. – PersonEntity: Name: NameFull: Erman, M. IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 09 Text: 2024 Supplement 2 Type: published Y: 2024 Identifiers: – Type: issn-print Value: 09237534 Numbering: – Type: volume Value: 35 Titles: – TitleFull: Annals of Oncology Type: main |
| ResultId | 1 |